Announced Wed, 24 Jun · 17:47 IST
Subsidiary gets 2 drug license suspensions in Andhra Pradesh
Business Updates View source PDF
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-5.0%1-day move
₹842.00
prior close
₹842.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.2+0.3+0.9-5.0-4.0-2.9-2.6-2.3-3.1-4.9-14.5——
Up moveDown movePending
AI summary
Optival Health Solutions, a subsidiary of Medplus Health Services, received two 7-day suspension orders on drug licenses for stores in Andhra Pradesh—one at Kovvada Main Road and another at Bethemcherla Main Road. Orders were issued on June 23, 2026 under the Drugs and Cosmetics Act, 1940. Combined potential revenue loss is about Rs 2.92 lacs.
Likely market impact
Very minor financial impact, about Rs 2.92 lacs in potential revenue loss across two store closures.